Rubella Patents (Class 514/897)
  • Patent number: 6730319
    Abstract: The present invention relates to pharmaceutical compositions that contain a solid pharmaceutically active compound having a melting point ≧37° C. and a fatty acid or a fatty acid salt or a mixture of a fatty acid and a fatty acid salt. Such composition results in a depression in melting point to ≦37° C. upon contact with an aqueous solution thereby providing an improved outlook for absorption.
    Type: Grant
    Filed: May 23, 2002
    Date of Patent: May 4, 2004
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Karsten Maeder, Lukas Christoph Scheibler, Hans Steffen
  • Publication number: 20020054894
    Abstract: A cosmetic, dermatological, hygiene and/or pharmaceutical composition comprising a hydrophilic component and a fatty phase which comprises at least one volatile compound and at least one pasty fatty compound. The composition is, in particular, a composition having improved staying power. The use of the combination of a volatile compound and a pasty fatty compound to limit the transfer and/or migration of such a cosmetic, dermatological, hygiene and/or pharmaceutical composition comprising a hydrophilic compound.
    Type: Application
    Filed: September 14, 2001
    Publication date: May 9, 2002
    Inventors: Isabelle Agostini, Dolores Miguel-Colombel
  • Patent number: 6024952
    Abstract: A personal hand or body washing formulation includes a cationic polymer and an anionic emollient which apparently combine to give a sparingly soluble complex, which is deposited on the skin and is difficult to remove. The deposition results in improved skin feel, including skin softness, skin moisture, skin hydration and skin smoothness. Skin appearance is approved as well. Exemplary cationic polymers include polyquaternium 6, while a preferred anionic emollient is sulfated castor oil. The complex also finds use as the conditioning agent of a cleansing and conditioning shampoo.
    Type: Grant
    Filed: September 12, 1997
    Date of Patent: February 15, 2000
    Assignee: The Andrew Jergens Company
    Inventors: David C. Story, Robert E. Gott, M. Tobias Asbury, Kevin Phifer, F. Anthony Simion
  • Patent number: 5001119
    Abstract: Compounds of the formula: ##STR1## are useful as anti-cancer, anti-obesity, anti-diabetic, anti-coronary agents, anti-aging agents, anti-hypolipidemic agents and anti-autoimmune agents.
    Type: Grant
    Filed: November 25, 1987
    Date of Patent: March 19, 1991
    Inventors: Arthur G. Schwartz, Marvin L. Lewbart
  • Patent number: 4714707
    Abstract: Aryl substituted diazaheterocyclic amines and their use in the treatment of gastrointestinal motility dysfunctions.
    Type: Grant
    Filed: January 13, 1984
    Date of Patent: December 22, 1987
    Assignee: Rorer Pharmaceutical Corporation
    Inventors: Donald E. Kuhla, William L. Studt, Henry F. Campbell, John Yelnosky